Franklin Biotechnology Discovery A - FBDIX
10355 views
Rate Now: 1 2 3 4

average rating: 0.00 / 0 ratings
DESCRIPTION:

Date updated:12-11-2007

This fund has a Morningstar rating of 2 stars and is run by Evan McCulloch. McCulloch is a portfolio manager with Franklin Advisers, his employer since 1992. He first joined the company as a management trainee. He holds the Chartered Financial Analyst designation. Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.


Current Returns:

1-Year: -0.23%
3-Year: 5.30%
5-Year: 11.74%

As of 9/30/07

symbol name last price % change open
  • +
  • GILD
    Gilead Sciences
  • $47.10
  • -0.38%
  • $47.09

No Analysis added

People owning GILD also tend to own: ACLALXNBMRNCELGCVHCVSESRX

TheStreet.com Rating: A- What is this?

  • +
  • CELG
    Celgene Corporati
  • $61.30
  • -0.99%
  • $61.82

No Analysis added

People owning CELG also tend to own: GTIACIRADSTXNVARASHBNI

TheStreet.com Rating: C+ What is this?

  • +
  • DNA
    N/a
  • $80.43
  • 0.00
  • $80.43

No Analysis added

People owning DNA also tend to own: AAPLDSCMGOOGXOMDWELXGLW

TheStreet.com Rating: No Rating What is this?

  • +
  • AMGN
    Amgen Inc.
  • $57.49
  • -0.50%
  • $57.45

No Analysis added

People owning AMGN also tend to own: BHICMCSACOFCVXDOWEBAYFDX

TheStreet.com Rating: B What is this?

  • +
  • GENZ
    Genzyme Corporati
  • $57.26
  • -0.59%
  • $57.38

No Analysis added

People owning GENZ also tend to own: AMLNANXBBIBBI.BBIIBCITCYBX

TheStreet.com Rating: C+ What is this?

  • +
  • PDLI
    Pdl Biopharma
  • $6.90
  • +1.62%
  • $6.83

No Analysis added

People owning PDLI also tend to own: AMDEXELTASRAFFXBVFAIBBHI

TheStreet.com Rating: C What is this?

  • +
  • VRTX
    Vertex Pharmaceut
  • $43.00
  • -0.05%
  • $42.97

No Analysis added

People owning VRTX also tend to own: EXPEIACIMCDXECHGSIIDIXITMN

TheStreet.com Rating: D- What is this?

  • +
  • MYGN
    Myriad Genetics
  • $23.64
  • 0.00%
  • $N/A

No Analysis added

People owning MYGN also tend to own: ABTACLAETALXNBAXBDXBIIB

TheStreet.com Rating: B- What is this?

previous next

Portfolio not tracked!

  • No Blogs Found

Comments not available

ADD YOUR COMMENTS:

Dividend-Boosting Stocks: Wal-Mart

By Jonas Elmerraji Posted on March 12, 2010 Dividend-paying companies took a mini-break from hiking their payouts to shareholders last week. Only 14 companies announced...

03.12.10 | 14:15 PM
Jim Cramer's Portfolios of the Week

By Roberto Pedone Posted on March 12, 2010 According to Jim Cramer, the stock market is trading higher for some very good reasons! In a March 11 RealMoney.com blog pos...

03.12.10 | 08:40 AM
Must-See Charts: Bank of America...

By Jonas Elmerraji Posted on March 11, 2010 The S&P 500 refuses to back down from its rally after posting gains in eight of the last 10 trading days. That’s a colossa...

03.11.10 | 10:37 AM
"Fast Money" Portfolio...

By Roberto Pedone Posted on March 11, 2010 According to CNBC’s “Fast Money” traders, M&A activity is what will likely be the big driver going forward for the stoc...

03.11.10 | 08:29 AM
more articles
Nymph's Trading Daily Trading Diary
04.13.09 | 01:10 AM From author Trading Nymph
The Presidential/Political Thread
01.02.08 | 08:05 AM From author Dave Cox
Cell Tower Play
03.12.10 | 12:49 PM From author Danee
If you could choose one stock to...
03.05.10 | 19:25 PM From author WilliamAndersen
more forums
today 's lists
Biggest % Losers

Here is the stock list of some of the largest % losers from Mar. 12, 2010. more

Rising on Unusual Volume

Here are some stocks that moved up on unusual volume on Mar. 12, 2010. more

Analyst Upgrades

Analyst Upgrades and EPS estimate changes for Mar. 12, 2010. more